207 related articles for article (PubMed ID: 20973164)
1. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
Martin H
Mutat Res; 2010 Aug; 690(1-2):57-63. PubMed ID: 20973164
[TBL] [Abstract][Full Text] [Related]
2. Role of PPAR-gamma in inflammation. Prospects for therapeutic intervention by food components.
Martin H
Mutat Res; 2009 Oct; 669(1-2):1-7. PubMed ID: 19563816
[TBL] [Abstract][Full Text] [Related]
3. Peroxisome proliferator-activated receptor gamma agonists as therapy for chronic airway inflammation.
Belvisi MG; Hele DJ; Birrell MA
Eur J Pharmacol; 2006 Mar; 533(1-3):101-9. PubMed ID: 16458290
[TBL] [Abstract][Full Text] [Related]
4. Evidence that peroxisome proliferator-activated receptor γ suppresses squamous carcinogenesis through anti-inflammatory signaling and regulation of the immune response.
Ren L; Konger RL
Mol Carcinog; 2019 Sep; 58(9):1589-1601. PubMed ID: 31111568
[TBL] [Abstract][Full Text] [Related]
5. Probing the intermolecular interactions of PPARγ-LBD with polyunsaturated fatty acids and their anti-inflammatory metabolites to infer most potential binding moieties.
Muralikumar S; Vetrivel U; Narayanasamy A; N Das U
Lipids Health Dis; 2017 Jan; 16(1):17. PubMed ID: 28109294
[TBL] [Abstract][Full Text] [Related]
6. The many faces of PPARgamma: anti-inflammatory by any means?
Szanto A; Nagy L
Immunobiology; 2008; 213(9-10):789-803. PubMed ID: 18926294
[TBL] [Abstract][Full Text] [Related]
7. Pro-inflammatory cytokines negatively regulate PPARγ mediated gene expression in both human and murine macrophages via multiple mechanisms.
Nagy ZS; Czimmerer Z; Szanto A; Nagy L
Immunobiology; 2013 Nov; 218(11):1336-44. PubMed ID: 23870825
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.
Abdelrahman M; Sivarajah A; Thiemermann C
Cardiovasc Res; 2005 Mar; 65(4):772-81. PubMed ID: 15721857
[TBL] [Abstract][Full Text] [Related]
9. 13-Oxo-ODE is an endogenous ligand for PPARgamma in human colonic epithelial cells.
Altmann R; Hausmann M; Spöttl T; Gruber M; Bull AW; Menzel K; Vogl D; Herfarth H; Schölmerich J; Falk W; Rogler G
Biochem Pharmacol; 2007 Aug; 74(4):612-22. PubMed ID: 17604003
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptors (PPARs) and the human skin: importance of PPARs in skin physiology and dermatologic diseases.
Sertznig P; Seifert M; Tilgen W; Reichrath J
Am J Clin Dermatol; 2008; 9(1):15-31. PubMed ID: 18092840
[TBL] [Abstract][Full Text] [Related]
11. New pharmacological perspectives and therapeutic potential of PPAR-gamma agonists.
Alarcón de la Lastra C; Sánchez-Fidalgo S; Villegas I; Motilva V
Curr Pharm Des; 2004; 10(28):3505-24. PubMed ID: 15579048
[TBL] [Abstract][Full Text] [Related]
12. PPAR Gamma: From Definition to Molecular Targets and Therapy of Lung Diseases.
Carvalho MV; Gonçalves-de-Albuquerque CF; Silva AR
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467433
[TBL] [Abstract][Full Text] [Related]
13. Function of PPARgamma and its ligands in lung cancer.
Li MY; Lee TW; Yim AP; Chen GG
Crit Rev Clin Lab Sci; 2006; 43(2):183-202. PubMed ID: 16517422
[TBL] [Abstract][Full Text] [Related]
14. A widely used retinoic acid receptor antagonist induces peroxisome proliferator-activated receptor-gamma activity.
Schupp M; Curtin JC; Kim RJ; Billin AN; Lazar MA
Mol Pharmacol; 2007 May; 71(5):1251-7. PubMed ID: 17290005
[TBL] [Abstract][Full Text] [Related]
15. Phytochemical drug candidates for the modulation of peroxisome proliferator-activated receptor γ in inflammatory bowel diseases.
Venkataraman B; Ojha S; Belur PD; Bhongade B; Raj V; Collin PD; Adrian TE; Subramanya SB
Phytother Res; 2020 Jul; 34(7):1530-1549. PubMed ID: 32009281
[TBL] [Abstract][Full Text] [Related]
16. Conjugated linoleic acid decreases production of pro-inflammatory products in macrophages: evidence for a PPAR gamma-dependent mechanism.
Yu Y; Correll PH; Vanden Heuvel JP
Biochim Biophys Acta; 2002 Apr; 1581(3):89-99. PubMed ID: 12020636
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms of peroxisome proliferator activated receptor γ regulation by non-steroidal anti-inflammatory drugs.
Puhl AC; Milton FA; Cvoro A; Sieglaff DH; Campos JC; Bernardes A; Filgueira CS; Lindemann JL; Deng T; Neves FA; Polikarpov I; Webb P
Nucl Recept Signal; 2015; 13():e004. PubMed ID: 26445566
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
19. Fatty acids, eicosanoids and PPAR gamma.
Marion-Letellier R; Savoye G; Ghosh S
Eur J Pharmacol; 2016 Aug; 785():44-49. PubMed ID: 26632493
[TBL] [Abstract][Full Text] [Related]
20. Platelets as a novel target for PPARgamma ligands : implications for inflammation, diabetes, and cardiovascular disease.
Ray DM; Spinelli SL; O'Brien JJ; Blumberg N; Phipps RP
BioDrugs; 2006; 20(4):231-41. PubMed ID: 16831022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
